Ruhrmann S, Bechdolf A, Kühn K-U, Wagner M, Schultze-Lutter F, Janssen B, Maurer K, Häfner H, Gaebel W, Möller H-J, Maier W, Klosterkötter J
Department of Psychiatry and Psychotherapy, University Hospital of the University of Cologne, Kerpener Strasse 62, 50924 Cologne, Germany.
Br J Psychiatry Suppl. 2007 Dec;51:s88-95. doi: 10.1192/bjp.191.51.s88.
People in a putatively late prodromal state not only have an enhanced risk for psychosis but already suffer from mental and functional disturbances.
To evaluate the acute effects of a combined supportive and antipsychotic treatment on prodromal symptoms.
Putatively prodromal individuals were randomly assigned to a needs-focused intervention without (n=59) or with amisulpride (n=65). Outcome measures at 12-weeks effects were prodromal symptoms, global functioning and extrapyramidal side-effects.
Amisulpride plus the needs-focused intervention produced superior effects on attenuated and full-blown psychotic symptoms, basic, depressive and negative symptoms, and global functioning. Main side-effects were prolactin associated.
Coadministration of amisulpride yielded a marked symptomatic benefit. Effects require confirmation by a placebo-controlled study.
处于假定的前驱期状态的人不仅患精神病的风险增加,而且已经患有精神和功能障碍。
评估支持性治疗与抗精神病药物联合治疗对前驱症状的急性影响。
将假定的前驱期个体随机分为无氨磺必利的以需求为导向的干预组(n = 59)和有氨磺必利的干预组(n = 65)。12周疗效的结局指标为前驱症状、整体功能和锥体外系副作用。
氨磺必利加以需求为导向的干预对减轻和全面发作的精神病性症状、基本症状、抑郁症状和阴性症状以及整体功能产生了更好的效果。主要副作用与催乳素有关。
联合使用氨磺必利产生了显著的症状改善。其效果需要通过安慰剂对照研究来证实。